222 related articles for article (PubMed ID: 31976021)
1. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues.
Kind S; Merenkow C; Büscheck F; Möller K; Dum D; Chirico V; Luebke AM; Höflmayer D; Hinsch A; Jacobsen F; Göbel C; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Clauditz TS; Simon R; Sauter G; Wilczak W; Bawahab AA; Izbicki JR; Perez D; Marx A
Dis Markers; 2019; 2019():4928315. PubMed ID: 31976021
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
Menz A; Weitbrecht T; Gorbokon N; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R
Mol Med; 2021 Feb; 27(1):16. PubMed ID: 33588765
[TBL] [Abstract][Full Text] [Related]
3. A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.
Kind S; Jaretzke A; Büscheck F; Möller K; Dum D; Höflmayer D; Hinsch A; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Simon R; Wilczak W; Lebok P; Witzel I; Müller V; Schmalfeldt B; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Krech T; Krech RH; von der Assen A; Bawahab AA; Burandt E
Mol Carcinog; 2019 Dec; 58(12):2306-2315. PubMed ID: 31545001
[TBL] [Abstract][Full Text] [Related]
4. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence.
Kind S; Kluth M; Hube-Magg C; Möller K; Makrypidi-Fraune G; Lutz F; Lennartz M; Rico SD; Schlomm T; Heinzer H; Höflmayer D; Weidemann S; Uhlig R; Huland H; Graefen M; Bernreuther C; Tsourlakis MC; Minner S; Dum D; Hinsch A; Lübke AM; Simon R; Sauter G; Marx A; Polonski A
Biomed Res Int; 2020; 2020():5845374. PubMed ID: 33195694
[TBL] [Abstract][Full Text] [Related]
5. CD138 Expression Is Observed in the Urothelial Epithelium and in Various Urothelial Carcinomas, and Cannot Be Evidence for Plasmacytoid Urothelial Carcinoma.
Goto K
Int J Surg Pathol; 2016 Oct; 24(7):614-9. PubMed ID: 27305940
[TBL] [Abstract][Full Text] [Related]
6. Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms: a tissue microarray study of 1,754 cases.
Kambham N; Kong C; Longacre TA; Natkunam Y
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):304-10. PubMed ID: 16280658
[TBL] [Abstract][Full Text] [Related]
7. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues.
Burdelski C; Jakani-Karimi N; Jacobsen F; Möller-Koop C; Minner S; Simon R; Sauter G; Steurer S; Clauditz TS; Wilczak W
Oncol Rep; 2018 Jan; 39(1):3-12. PubMed ID: 29115542
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD138 (Syndecan-1) in renal cell carcinoma is reduced with increasing nuclear grade.
Gökden N; Greene GF; Bayer-Garner IB; Spencer HJ; Sanderson RD; Gökden M
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):173-7. PubMed ID: 16785785
[TBL] [Abstract][Full Text] [Related]
9. CD138 (syndecan-1) expression in health and disease.
Palaiologou M; Delladetsima I; Tiniakos D
Histol Histopathol; 2014 Feb; 29(2):177-89. PubMed ID: 24150912
[TBL] [Abstract][Full Text] [Related]
10. Utility of CD138/syndecan-1 immunohistochemistry for localization of plasmacytes is tissue-dependent in B6 mice.
Meyerholz DK; Leidinger MR; Goeken JA; Businga TR; Akers A; Vizuett S; Kaemmer CA; Kohlmeyer JL; Dodd RD; Quelle DE
BMC Res Notes; 2022 Jun; 15(1):219. PubMed ID: 35752869
[TBL] [Abstract][Full Text] [Related]
11. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
[TBL] [Abstract][Full Text] [Related]
12. CD138 (syndecan-1) expression in bone-forming tumors.
Nunez AL; Siegal GP; Reddy VV; Wei S
Am J Clin Pathol; 2012 Mar; 137(3):423-8. PubMed ID: 22338054
[TBL] [Abstract][Full Text] [Related]
13. The Intensity and Pattern of Syndecan-1 (CD138) Expression in Normal and Diseased Livers.
Atique M; Javed R; Seerat I; Atique U; Bhatti T
Cureus; 2023 Oct; 15(10):e46718. PubMed ID: 38022112
[TBL] [Abstract][Full Text] [Related]
14. A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells.
Sharpe B; Alghezi DA; Cattermole C; Beresford M; Bowen R; Mitchard J; Chalmers AD
Prostate; 2017 May; 77(13):1312-1324. PubMed ID: 28744948
[TBL] [Abstract][Full Text] [Related]
15. The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.
Kilic E; Tennstedt P; Högner A; Lebok P; Sauter G; Bokemeyer C; Izbicki JR; Wilczak W
Virchows Arch; 2016 Apr; 468(4):483-92. PubMed ID: 26818834
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive analysis of PAX8 expression in human epithelial tumors.
Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS
Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors.
Lennartz M; Ullmann VS; Gorbokon N; Uhlig R; Rico SD; Kind S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Putri D; Clauditz TS; Fraune C; Hinsch A; Jacobsen F; Krech T; Lebock P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A
APMIS; 2023 Feb; 131(2):77-91. PubMed ID: 36269681
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors.
Menz A; Bauer R; Kluth M; Marie von Bargen C; Gorbokon N; Viehweger F; Lennartz M; Völkl C; Fraune C; Uhlig R; Hube-Magg C; De Wispelaere N; Minner S; Sauter G; Kind S; Simon R; Burandt E; Clauditz T; Lebok P; Jacobsen F; Steurer S; Wilczak W; Krech T; Marx AH; Bernreuther C
Hum Pathol; 2021 Sep; 115():19-36. PubMed ID: 34102222
[TBL] [Abstract][Full Text] [Related]
19. p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors.
Steurer S; Riemann C; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Menz A; Fisch M; Rink M; Bernreuther C; Lebok P; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Dum D; Simon R; Minner S; Burandt E; Krech R; Krech T; Marx AH
Biomark Res; 2021 Jan; 9(1):7. PubMed ID: 33494829
[TBL] [Abstract][Full Text] [Related]
20. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.
Turner JR; Odze RD; Crum CP; Resnick MB
Hum Pathol; 1997 Jun; 28(6):740-4. PubMed ID: 9191010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
